ESAP 2024
(8)
Image For Activity Cover
Availability
On-Demand
2 Courses
Expires on Dec 31, 2026
Cost
Member: $250.00
Non-Member: $350.00
In-Training Member: $199.00
Resident Member: $199.00
Resident Non-Member: $350.00
Credit Offered
40 AMA PRA Category 1 Credits
40 ABIM-MOC Points
40 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
The Endocrine Self-Assessment Program (ESAP™) is a self-study curriculum designed for physicians looking to reinforce existing knowledge, identify knowledge gaps, and stay current with the latest advances in endocrinology. ESAP 2024 consists of 120 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each answer option, with references. ESAP is updated annually with new questions. For accessibility for international practitioners, SI units are included.

Learning Options
Assess your clinical knowledge through different learning modes:
  • Learning Mode (required for CME and MOC): This is the "traditional" ESAP. Answer 120 questions and receive immediate feedback and view the detail answer rationale. This mode must be completed with a passing score of 70% in order to earn CME and MOC.
    • Each attempt will only reset what was marked incorrect. Full reset is available following a passing score.
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like. Feedback will be provided after completion of the exam.
    • Topical Learning Mode: Within Mock Exam Mode, you have the option to create your own exams by choosing the topic(s) to be included
  • Both modes are set to randomized sequence to ensure an accurate representation of your competency improvements following each attempt.


METHOD OF PARTICIPATION
This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. Participants must achieve a minimum score of 70% to claim CME credit and MOC points. After initially completing the module(s), if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Credit is only available on the standard ESAP learning mode.

LAST REVIEW DATE: December 2023

ACTIVITY RELEASE DATE: February 2024

ACTIVITY EXPIRATION DATE: December 31, 2026 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABIM Medical Knowledge MOC points)

ESAP is is a self-study curriculum designed for physicians looking to reinforce existing knowledge, identify knowledge gaps, and stay current with the latest advances in endocrinology.

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
  • Evaluate endocrine and metabolic manifestations of systemic disorders.
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 40.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.


Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 40.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME, please contact the Endocrine Society at info@endocrine.org.

Thomas J. Weber, MD - Program Co-Chair
Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University Medical Center

Deepika Reddy, MD - Program Co-Chair
Assistant Professor
Division of Diabetes, Endocrinology, and Metabolism
University of Utah Healthcare

Danit Ariel, MD, MS
Associate Professor of Medicine
Division of Endocrinology, Gerontology, and Metabolism
Stanford University School of Medicine

Gregory Clines, MD, PhD
Associate Professor of Internal Medicine
Metabolism, Endocrinology, and Diabetes Division
University of Michigan

Nazanene H. Esfandiari, MD
Professor of Medicine
Metabolism, Endocrinology, and Diabetes Division

University of Michigan

Mathis Grossmann, MD, PhD
Professor of Medicine
University of Melbourne
Austin Health

Mark Gurnell, MBBS, MA (Med Ed), PhD
Professor of Clinical Endocrinology & Clinical SubDean
Wellcome Trust-MRC Institute of Metabolic Science & School of Clinical Medicine
University of Cambridge

Erik Imel, MD
Professor of Medicine and Pediatrics
Indiana University School of Medicine

Adriana Ioachimescu, MD, PhD
Professor of Medicine
Endocrinology and Molecular Medicine Division
Medical College of Wisconsin

Sarah E. Mayson, MD
Associate Professor of Medicine
Director of the Endocrinology Fellowship Program
Division of Endocrinology, Metabolism, and Diabetes
University of Colorado School of Medicine

Kevin M. Pantalone, DO
Professor of Medicine
Director of Diabetes Initiatives
Department of Endocrinology
Cleveland Clinic

Meera Shah, MB ChB
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Consultant, Division of Endocrinology
Mayo Clinic – Rochester

Anu Sharma, MBBS
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, and Metabolism
University of Florida

Aniket R. Sidhaye, MD
Associate Professor of Clinical Medicine
Program Director, Adult Endocrinology Fellowship
Johns Hopkins University School of Medicine

Vinaya Simha, MBBS, MD
Associate Professor of Medicine
Mayo Clinic College of Medicine
Mayo Clinic – Rochester

Elias Spanakis, MD
Associate Professor of Medicine
University of Maryland School of Medicine

Adina F. Turcu, MD, MS
Associate Professor of Internal Medicine
Metabolism, Endocrinology, and Diabetes Division
University of Michigan

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported relevant financial relationship(s): Mathis Grossmann, MD, PhD, receives funding from Bayer Pharma and Otsuka. He is a speaker for Bayer Pharmaceuticals and Besins Healthcare and is an associate editor for the European Journal of Endocrinology. Mark Gurnell, MBBS, MA (Med Ed), PhD, serves on the advisory board for AstraZeneca, HRA Pharma, and Recordati. He is on the speakers bureau for AstraZeneca and Novartis. Adrianna Ioachimescu, MD, PhD, is a consultant for Chiasma, Crinetics, Camurus, HRA Pharma, Strongbridge, Recordati, and Tiburio Therapeutics. Her institution has also received grants from Chiasma, Strongbridge, and Recordati. Erik Imel, MD, is a clinical trial investigator for Amgen, Calciolytix, Spruce, Neurocrine, Sanofi, and Ultragenyx. He serves on advisory boards for Kyowa Hakko Kirin and Ultragenyx. He is a consultant for Alexion, and serves on data and safety monitoring boards for Inozyme and Agios. Kevin M. Pantalone, DO, receives research support from Bayer, Merck, Novo Nordisk, and Twinhealth. He is a speaker for AstraZeneca, Corcept Therapeutics, Merck, and Novo Nordisk and is a consultant for AstraZeneca, Bayer, Corcept Therapeutics, Diasome, Eli Lilly, Merck, Novo Nordisk, and Sanofi. He is a principal investigator for Eli Lilly, Novo Nordisk, and Twinhealth. Meera Shah, MB ChB, is a research collaborator for Pendulum Therapeutics, Inc. Compensation for her time is paid to her institution, Mayo Clinic. Vinaya Simha, MD, serves on an advisory board for Pfizer. Elias Spanakis, MD, has received unrestricted research support from Dexcom (to Baltimore VA Medical Center and to the University of Maryland) for conducting clinical trials. Adina Turcu, MD, MS, receives grant funds from the National Institutes of Health. She is an advisor for CinCor. She is an investigator in a sponsor-initiated clinical trial for Novartis and is a consultant for Crinetics, Poxel, Chiasma, and PhaseBio. Thomas J. Weber, MD, serves as a primary investigator and consultant for Ultragenyx. He is on the FDA Endocrine and Metabolic Drug Advisory Committee.

The following faculty reported no relevant financial relationships: Danit Ariel, MD, MS; Gregory A. Clines, MD, PhD; Nazanene H. Esfandiari, MD; Sarah E. Mayson, MD; Deepika Reddy, MD; Anu Sharma, MD; Aniket Sidhaye, MD 

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By